ClearPoint Neuro, Inc.
CLPT
$10.00
-$0.40-3.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.03M | -5.39M | -4.97M | -4.41M | -4.15M |
| Total Depreciation and Amortization | 334.00K | 471.00K | 495.00K | 463.00K | 474.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 22.00K | 14.00K | 15.00K |
| Total Other Non-Cash Items | 2.13M | 1.91M | 1.90M | 1.44M | 1.36M |
| Change in Net Operating Assets | -2.61M | 1.76M | 1.35M | -172.00K | -1.54M |
| Cash from Operations | -6.17M | -1.24M | -1.20M | -2.67M | -3.84M |
| Capital Expenditure | -183.00K | -263.00K | -12.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -183.00K | -263.00K | -12.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -10.00M | -- | -- |
| Issuance of Common Stock | 21.00K | 121.00K | 0.00 | 288.00K | 16.20M |
| Repurchase of Common Stock | -1.31M | -84.00K | -61.00K | -128.00K | -151.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.00K | -- | -- | -- | -- |
| Cash from Financing | -1.36M | 37.00K | -10.06M | 160.00K | 16.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.72M | -1.47M | -11.27M | -2.51M | 12.21M |